Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20190717044241N1
IRCT20190717044241N1
Recruiting
Phase 1

Cell therapy using human-derived placental-derived mesenchymal stem cells in patients with Acute liver failure: clinical trial phase I

Tehran University of Medical Sciences0 sites5 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
5
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •ALF: The occurrence of hepatic encephalopathy is less than 8 weeks after the onset of jaundice in a disease that does not have a history of known liver disease.
  • •All patients with ALF or ACLF are admitted to hospital at Shariati Hospital and Imam Khomeini Hospital.

Exclusion Criteria

  • •Patient dissatisfaction
  • •Pregnant patient
  • •Age less than 17 years
  • •Patient with known active malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
The effect of MSCs transplantation in the treatment of SPMSMultiple sclerosis.Multiple sclerosis
IRCT20210614051576N1Tehran University of Medical Sciences5
Recruiting
Phase 1
Placental Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection: A Phase 1-2 Clinical TrialAcute Respiratory Distress Syndrome of COVID-19.COVID-19U07.1
IRCT20200413047063N1Execution of Imam Khomeini's Order20
Recruiting
Phase 2
Isolation , Purification, Characterization and Commercialization of Stem Cells From Fetal Membrane layers and Their Use for the Treatment of Patients With Acute Respiratory Distress Syndrome (ARDS)Acute Respiratory Distress Syndrome.Acute Respiratory Distress Syndrome
IRCT2017010531786N1Breast Cancer Research Center (BCRC), Motamed Cancer Institute, Tehran University of Medical science15
Recruiting
Phase 1
Therapeutic angiogenesis by cell transplantation using dedifferentiated fat (DFAT) cells.
JPRN-jRCTb030190212Tanaka Masashi4
Completed
Not Applicable
Hominis Placenta Pharmacopuncture for treating insomnia disorder
KCT0005127Pusan National University Korean Medicine Hospital51